Mitsubishi Tanabe Pharma America, Inc. announced RADICAVA ™ (edaravone), an intravenous therapy indicated for all adult patients diagnosed with amyotrophic lateral sclerosis...
Read more
Motif Bio plc ,the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced that the last patient has completed...
Read more
CMP Pharma announced that the US FDA has granted final approval of the company’s NDA for CaroSpir® (Spironolactone Oral Suspension,...
Read more
Takeda Pharma and Molecular Templates, Inc. announced a collaboration agreement for oncology drug discovery programs. The collaboration will apply Molecular...
Read more
Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral...
Read more
X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 inhibitor drugs to improve immune cell trafficking to treat...
Read more
Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc. announce top-line results in a Phase II study of topical TV-45070 in...
Read more
Samumed announced that the U.S. FDA has granted SM04646, a novel small molecule Wnt pathway inhibitor, an Orphan Drug Designation...
Read more
DelMar Pharmaceuticals , a biopharmaceutical company focused on the development of new cancer therapies announced that the HGRAC, has approved...
Read more
Using your body’s own cells, engineering them to target tumors and cure cancer sounds like something from a Sci-Fi movie...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
